Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
Share This Page

Overexpression of cofactor of BRCA1 in HepG2 cells: A step towards understanding the role of COBRA1 in hepatocellular carcinoma

International Conference on Cancer Epigenetics and Biomarkers
October 26-28, 2017 Osaka, Japan

Razan Jamil Masad

The American University in Cairo, Egypt

Posters & Accepted Abstracts: Arch Can Res

Abstract:

Cofactor of BRCA1 (COBRA1) is a BRCA1 interacting protein that represents one of the four subunits of the negative elongation factor (NELF) complex. NELF is known by its ability to stall RNA Polymerase II during the early phase of transcription elongation, resulting in repressed transcription of several genes including ones associated with tumorigenesis of different cancer types. While it was found to be down-regulated in breast cancer, COBRA1 was found to be up-regulated in the upper gastrointestinal carcinoma. Up to date, the role of COBRA1 in hepatocellular carcinoma (HCC) is unclear. We have previously demonstrated that silencing of COBRA1 in the HCC cell line HepG2, significantly inhibited the proliferation and migration potentials of the cells. Here, we investigated the effect of ectopic expression of COBRA1 on HepG2 cells proliferation and migration. Lipofectamine 3000 was used to transfect HepG2 cells with a pCMV5-HCOBRA1 plasmid. The transfection efficiency was determined by the percentage of EGFP positive cells (pEGFP-N1+) via fluorescent microscope, semi-quantitative RT-PCR as well as western blot analysis. The cells proliferation and migration following COBRA1 overexpression were assessed using the Trypan blue dye exclusion method and the wound-healing assays respectively. The semi-quantitative RT-PCR was used to analyze the mRNA expressions of the other NELF subunits, TFF1 and TFF3 genes, which are known to be regulated by the NELF complex, as well as other tumorigenesis related genes. Our results revealed that COBRA1 transfected cells exhibited a comparable proliferation and migration rates to non-transfected cells. These results were accompanied by an insignificant effect of COBRA1 over-expression on the levels of the proliferation marker-Ki-67 and the anti-apoptotic gene-Survivin. Also, the mRNA levels of the other NELF subunits, TFF1 and TFF3 were found to be comparable among all the tested groups. Collectively, our results suggest that the proposed involvement of COBRA1 in HCC is supported by and dependent on the assembly of the active NELF complex, which requires the expression of all four NELF subunits. Moreover, COBRA1 mediated role in HCC tumorigenesis might be due to mechanisms and regulatory pathways other than the ones examined here. However, further studies are required to confirm these notions.